ATLANTA--(BUSINESS WIRE)--Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced a new Submission Checking Service offering based on its Web Submission Data Manager (WebSDM™) application. Developed under a Cooperative Research and Development Agreement between the FDA and Phase Forward’s Lincoln Technologies safety division, WebSDM gives organizations a means for testing FDA submissions for compliance with the Clinical Data Interchange Standards Consortium’s (CDISC) Study Data Tabulation Model (SDTM) standard for human clinical trials.
